🚨 PhD position available 🚨 👀 We are excited to announce a fully funded PhD position in our lab, focused on developing personalized induced pluripotent stem cell (iPSC)-based models to study inherited retinal diseases as part of the Lifelong VISION consortium!

💡 Light matters 💡 Despite major advances in generating retinal cells in vitro, these cells are typically cultured in the dark. But why would cells develop light-sensitive features if there is no light around?

Congratulations Owen and many thanks to Alex and Amanda.

Congratulations Owen on your PhD defence 🥳🎉🥂huge thank you to examiners @jandritu.bsky.social and @amandajcarr.bsky.social

🚨𝗙𝗶𝗻𝗮𝗹 𝗪𝗲𝗲𝗸 𝘁𝗼 𝗔𝗽𝗽𝗹𝘆 𝘁𝗼 𝟭𝟮 𝗙𝘂𝗹𝗹𝘆 𝗙𝘂𝗻𝗱𝗲𝗱 𝗣𝗵𝗗 𝗣𝗼𝘀𝗶𝘁𝗶𝗼𝗻𝘀 𝘄𝗶𝘁𝗵 𝗘𝗙𝗙𝗲𝗰𝗧🚨 🔬 Join an international network driving innovative treatments and delivery methods for a variety of disorders with leading experts in RNA therapeutics 🌍 🔗 𝗔𝗽𝗽𝗹𝘆 𝗻𝗼𝘄: euraxess.ec.europa.eu/jobs/296420 more info: www.effect-dn.eu

5 Partners & 1 Associated partner of #EFFecT are present at SMOT (Synergistic Meeting on Oligonucleotide Therapeutics) celebrating #[email protected] @dutchantisense.bsky.social @uvsq.bsky.social #ucl @cbm-csic-uam.bsky.social @varechavala.bsky.social

🚨 Only 3 Weeks Left to Apply! 🚨 Passionate about antisense oligonucleotide (ASO) therapeutics? Looking for a PhD opportunity in this cutting-edge field? The EFFecT consortium is recruiting!

Check out our latest work! Preclinical in vitro and safety and in vivo biodistribution of #antisense #oligonucleotides targeting a recurrent genetic variant in ABCA4 present in patients with #Stargardt disease. A big first step towards therapeutic intervention. www.nature.com/articles/s43...

Today part of the @dutch-antisense.bsky.social organizing committee visited the venues for the #DATS2025 in Groningen! We cannot wait to welcoming you in June! Registrations will open soon, stay tuned! www.dutchantisense.org @ronaldbuijsen.bsky.social